• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GraniteShares Expands YieldBOOST™ Lineup with Two New ETFs Targeting RIOT Platforms and Hims & Hers Health (RTYY and HMYY)

    12/2/25 8:00:00 AM ET
    $HIMS
    $RIOT
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $HIMS alert in real time by email

    New York, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- GraniteShares, a one of the leading issuer of exchange-traded funds (ETFs), today announced the launch of two new additions to its growing YieldBOOST™ family, offering investors additional ways to access income opportunities across high-growth and highly followed segments of the equity market.

    TickerFundUnderlying Company
    RTYYGraniteShares YieldBOOST™ RIOT ETFRiot Platforms, Inc. (NASDAQ:RIOT)
    HMYYGraniteShares YieldBOOST™ HIMS ETFHims & Hers Health, Inc. (NYSE:HIMS)



    Both ETFs are designed to generate potential income by selling options on leveraged ETFs that track 2x daily leveraged price movement to their respective underlying companies.

    RTYY - GraniteShares YieldBOOST™ RIOT ETF seeks to generate income through options¹ strategies, primarily by selling put options² on leveraged ETFs that track the 2x Long RIOT Daily ETF. RTYY targets Riot Platforms, a major U.S.-based Bitcoin mining and digital infrastructure company known for its large-scale mining operations and participation in blockchain ecosystem development.

    HMYY - GraniteShares YieldBOOST™ HIMS ETF follows a similar approach. It seeks to generate income through options¹ strategies, primarily by selling put options² on leveraged ETFs that track the 2x Long HIMS Daily ETF. HMYY is linked to Hims & Hers Health, a fast-growing telehealth platform focused on personalized wellness, digital healthcare delivery, and subscription-based treatment services.

    These new launches continue the evolution of GraniteShares' YieldBOOST™ platform a suite of ETFs that applies systematic options strategies to leveraged ETFs tied to innovative companies and emerging themes across the market.

    "We're pleased to introduce RTYY and HMYY as the latest additions to our expanding YieldBOOST™ options income suite, which reached over $649.5 million in AUM (as of November 28, 2025)," said Will Rhind, Founder and CEO of GraniteShares. "These funds are designed to bring the YieldBOOST™ methodology to widely followed companies in both digital assets and consumer health technology."

    GraniteShares' YieldBOOST™ ETFs have quickly gained traction among investors looking for alternative income strategies in equity markets. By combining innovation with transparent, exchange-traded access, GraniteShares continues to push the boundaries of what ETFs can deliver.

    About GraniteShares:

    GraniteShares is a global investment firm dedicated to creating and managing ETFs. Headquartered in New York City, GraniteShares provides products on U.S., U.K., German, French, and Italian stock exchanges. The firm is a market leader in leveraged single-stock ETFs and offers innovative investment solutions for high-conviction investors.

    Founded in 2016, GraniteShares focuses on alternative, innovative ETF solutions. Its U.S. lineup includes a broad-based commodity index fund, physically backed gold and platinum funds, and a high-income pass-through securities index fund.

    GraniteShares also offers a suite of leveraged single-stock ETFs, including those tied to NVIDIA, Coinbase, and Tesla. The company manages over $11.114 billion in assets under management as of November 28, 2025.

    For more information, visit www.graniteshares.com.

    1An option is a contract that gives the holder the right, but not the obligation to buy or sell a specific asset at a predetermined price on or before a specified date. Options are a type of derivative, meaning their value is derived from the underlying asset.

    2A put option is a contract that gives the buyer the right, but not the obligation, to sell an underlying asset at a specified price (the strike price) by or on a specific fate (the expiration date).

    RISK FACTORS & IMPORTANT INFORMATION

    The fund is newly launched and has risks associated with its limited operating history.

    Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the Funds, please call (844) 476 8747 or. Read the prospectus or summary prospectus carefully before investing.

    There is no guarantee that the Fund's investment strategy will be properly implemented, and an investor may lose some or all of its investment.

    An Investment in the Fund is not an investment in the Underlying RIOT and HIMS ETF

    The Fund's strategy will cap its potential gain if the Underlying RIOT and HIMS ETF's share increases in value

    The Fund's strategy is subject to all potential losses if the Underlying RIOT and HIMS ETF's share decline, which may not be offset but the income received by the Fund,

    The Fund does not invest directly in the Underlying RIOT and HIMS ETF,

    Fund shareholders are not entitled to any distribution paid by the Underlying RIOT and HIMS ETF.

    Shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from the returns.

    An investment in the Fund involves risk, including the possible loss of principal. The Fund is non-diversified and includes risks associated with the Fund concentrating its investments in a particular industry, sector, or geographic region which can result in increased volatility. The use of derivatives such as option contracts and swaps is subject to market risks that may cause their price to include Risk of the Underlying ETF, Derivatives Risk, A Risk, Put Writing Strategy Risk, Option Market Liquidity Risk. These and other risks can be found in the prospectus.

    This information is not an offer to sell or a solicitation of an offer to buy the shares of any Funds to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Please consult your tax advisor about the tax consequences of an investment in Fund shares, including the possible application of foreign, state, and local tax laws. You could lose money by investing in the ETFs. There can be no assurance that the investment objective of the Funds will be achieved. None of the Funds should be relied upon as a complete investment program.

    THE FUNDS ARE DISTRIBUTED BY ALPS DISTRIBUTORS, INC. GRANITESHARES IS NOT AFFILIATED WITH ALPS DISTRIBUTORS, INC.

    ©2025 GraniteShares Inc. All rights reserved. GraniteShares, GraniteShares ETFs, and the GraniteShares logo are registered and unregistered trademarks of GraniteShares Inc., in the United States and elsewhere. All other marks are the property of their respective owners.

    Media Contact:

    GraniteShares Inc.

    Attn: Media Relations

    222 Broadway, 21st Floor

    New York, NY 10038

    844-476-8747

    [email protected]



    Primary Logo

    Get the next $HIMS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HIMS
    $RIOT

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    1/12/2026$33.00In-line
    Evercore ISI
    Hims & Hers Health Inc.
    $HIMS
    12/9/2025$48.00Overweight
    Barclays
    Riot Platforms Inc.
    $RIOT
    11/19/2025$25.00Mkt Outperform
    Citizens JMP
    Hims & Hers Health Inc.
    $HIMS
    10/21/2025Sector Weight
    KeyBanc Capital Markets
    Riot Platforms Inc.
    $RIOT
    9/26/2025$19.00Neutral → Overweight
    Analyst
    Riot Platforms Inc.
    $RIOT
    9/26/2025$24.00Neutral → Buy
    Citigroup
    Riot Platforms Inc.
    $RIOT
    9/24/2025$26.00Buy
    Arete
    Riot Platforms Inc.
    $RIOT
    9/15/2025Buy
    Compass Point
    More analyst ratings

    $HIMS
    $RIOT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mouton Douglas bought $64,892 worth of shares (8,384 units at $7.74), increasing direct ownership by 70% to 20,384 units (SEC Form 4)

    4 - Riot Platforms, Inc. (0001167419) (Issuer)

    3/20/25 6:00:47 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Director Manuel Anja bought $132,260 worth of shares (5,000 units at $26.45) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    11/14/24 4:57:45 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Payne Christopher D bought $1,951,763 worth of shares (110,000 units at $17.74) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    5/22/24 4:16:26 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RIOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

    San Francisco, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Weight management concerns should be evaluated by a qualified healthcare professional. Hims GLP-1 Weight Loss is a prescription-only medication program available exclusively through licensed physician consultation. This content does not diagnose, treat, cure, or prevent any disease. Prescription approval is not guaranteed. If you purchase through links in this article, a commission may be earned at no additional cost to you. Purpose and Scope This release is an informational overview of publicly available disclosures for Hims GLP-1 Weight Loss

    2/5/26 8:51:30 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

    Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Wegovy®**. This needle-free treatment joins a full suite of weight loss solutions designed to meet the specific needs and preferences of individual customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205680502/en/ By leveraging nearly a decade of infrastructure investment to drive radical affordability, Hims & Hers is making personalized care more accessible than ever.

    2/5/26 9:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

    The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer Today, Hims & Hers Health, Inc. (NYSE:HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims & Hers' scale with GRAIL's innovative cancer screening technology to dramatically increase access to proactive care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026

    2/4/26 9:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RIOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Okupe Oluyemi exercised 5,262 shares at a strike of $5.01 and sold $139,108 worth of shares (5,262 units at $26.44) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    2/4/26 4:13:24 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Okupe Oluyemi exercised 9,067 shares at a strike of $6.27 and sold $275,114 worth of shares (9,067 units at $30.34) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    1/21/26 4:23:35 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Okupe Oluyemi exercised 5,986 shares at a strike of $9.16 and sold $306,453 worth of shares (9,070 units at $33.79), decreasing direct ownership by 3% to 91,617 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    1/7/26 4:16:02 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RIOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on Hims & Hers Health with a new price target

    Evercore ISI initiated coverage of Hims & Hers Health with a rating of In-line and set a new price target of $33.00

    1/12/26 8:13:43 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Barclays initiated coverage on Hims & Hers Health with a new price target

    Barclays initiated coverage of Hims & Hers Health with a rating of Overweight and set a new price target of $48.00

    12/9/25 8:50:15 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Citizens JMP initiated coverage on Riot Platforms with a new price target

    Citizens JMP initiated coverage of Riot Platforms with a rating of Mkt Outperform and set a new price target of $25.00

    11/19/25 8:58:32 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $HIMS
    $RIOT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Riot Platforms Inc.

    SCHEDULE 13G/A - Riot Platforms, Inc. (0001167419) (Subject)

    2/5/26 1:36:41 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Riot Platforms Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Riot Platforms, Inc. (0001167419) (Filer)

    1/16/26 4:15:19 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Amendment: Riot Platforms Inc. filed SEC Form 8-K: Leadership Update

    8-K/A - Riot Platforms, Inc. (0001167419) (Filer)

    1/5/26 5:15:10 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $HIMS
    $RIOT
    Leadership Updates

    Live Leadership Updates

    View All

    Riot Platforms Announces Chief Financial Officer Transition

    CASTLE ROCK, Colo., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or the "Company") today announced the appointment of Jason Chung as Chief Financial Officer of the Company, effective March 1, 2026. Chung succeeds Colin Yee, who has served as the Company's Chief Financial Officer since 2022. As part of this transition, Yee will continue to serve in his current capacity through March 1, 2026, after which he will transition to a Senior Advisor role to ensure a seamless transition and support the Company's strategic continuity. Chung currently serves as Riot's EVP, Head of Corporate Development & Strategy, and brings two decades of experience in investment ban

    1/2/26 5:20:00 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

    Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company's first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical companies, medtech innovators, policymakers, and regulators, with the goal of paving the way to the healthcare of the future - where the power of technology will be combined with the best of personalized care. She will lead the company's global public policy, regulatory, and government affairs functions. A former senior leader at the FDA, prosecutor f

    11/17/25 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Riot Platforms Announces Hiring of Jonathan Gibbs as Chief Data Center Officer to Lead Data Center Platform

    CASTLE ROCK, Colo., June 2, 2025 /PRNewswire/ -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"),  a Bitcoin-driven industry leader in the development of large scale data centers for high performance compute and bitcoin mining applications, today announced the hiring of Jonathan Gibbs as Chief Data Center Officer ("CDCO") to lead the development of Riot's data center platform. In this role, Jonathan will lead the strategic development and operations of this new platform, which will focus on building and operating state-of-the-art data centers specifically tailored to serve hyperscale and enterprise tenants.

    6/2/25 9:00:00 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $HIMS
    $RIOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hims & Hers Health Inc.

    SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

    11/12/24 3:52:47 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Hims & Hers Health Inc.

    SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

    11/4/24 1:33:02 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Hims & Hers Health Inc.

    SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

    11/4/24 12:09:24 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RIOT
    Financials

    Live finance-specific insights

    View All

    Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

    Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the c

    2/2/26 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Riot Announces Fee Simple Acquisition of Land and First Data Center Lease with AMD at the Rockdale Site

    Data center development and hyperscale leasing opportunity unlocked via fee simple acquisition of 200 acres of land underlying Riot's Rockdale SiteData center business firmly and rapidly established via execution of lease with AMD at Rockdale Site, with expected delivery beginning in January 2026 and completing in May 2026Data center portfolio of 1.7 GW of fully approved power capacity in one of the leading data center markets in the U.S. CASTLE ROCK, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, is pleased to announce a

    1/16/26 9:00:00 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

    Revenue of nearly $600 million, up 49% year-over-year in Q3 2025 Net income of nearly $16 million; Adjusted EBITDA of over $78 million in Q3 2025 Subscribers grew to almost 2.5 million, up 21% year-over-year in Q3 2025 Narrows full year 2025 revenue guidance to $2.335 billion to $2.355 billion and Adjusted EBITDA guidance to $307 million to $317 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com. "This quarter we continued to prove that our vision of helping tens of mill

    11/3/25 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care